Showing results (151-160 of 214) with videos related to
Sort By:
Pageof 22
Breast Cancer Research and Treatment|January 5, 2002
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factorE Fenig, Y Kanfi, Q Wang, et al.Advances in Therapy|October 12, 2012
Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacksMichael J Prematta, Againdra K Bewtra, Robyn J Levy, et al.Scientific Reports|November 11, 2023
Microbial community dynamics and cycling of plutonium and iron in a seasonally stratified and radiologically contaminated pondNancy Merino, Naomi L Wasserman, Fanny Coutelot, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugsL Wasserman, R Aviram, H Levavi, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2018
Real-World Experience with Peanut Oral Immunotherapy: Lessons Learned From 270 PatientsRichard L Wasserman, Angela R Hague, Deanna M Pence, et al.Immunotherapy|May 9, 2023
Development of a novel shared decision making aid for primary immunodeficiency diseasesSpiros Tzivelekis, Jordan Orange, Christine Poulos, et al.Medical Acupuncture|September 23, 2024
2021 American Society of Acupuncturists Survey on Acupuncturists' Backgrounds, Interests, and Attitudes toward Conducting ResearchSamantha J Allen, Lisa Conboy, Tuesday L Wasserman, et al.Surgical Endoscopy|August 28, 2014
Laparoscopic limited Heller myotomy without anti-reflux procedure does not induce significant long-term gastroesophageal refluxL C Zurita Macías Valadez, R Pescarus, T Hsieh, et al.Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.Expert Review of Clinical Immunology|February 1, 2012
Safety of L-proline as a stabilizer for immunoglobulin productsJohn B Hagan, Richard L Wasserman, Jeffrey S Baggish, et al.Pageof 22